Multiple myeloma electrocardiogram: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:


==Electrocardiogram==
==Electrocardiogram==
There are two indications for obtaining an electrocardiogram in the workup and management of multiple myeloma.
There are two indications for obtaining an [[electrocardiogram]] in the workup and management of [[multiple myeloma]]:


*'''Use of [[carfilzomib]]'''<ref name="pmid25471129">{{cite journal| author=Chari A, Hajje D| title=Case series discussion of cardiac and vascular events following carfilzomib treatment: possible mechanism, screening, and monitoring. | journal=BMC Cancer | year= 2014 | volume= 14 | issue=  | pages= 915 | pmid=25471129 | doi=10.1186/1471-2407-14-915 | pmc=4289164 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25471129  }} </ref>: Carfilzomib is a second-generation proteasome inhibitor that is used in previously treated multiple myeloma. This medication is usually given along with either dexamethasone or the combination of lenalidomide plus dexamethasone. Carfilzomib is known to cause cardiomyopathy and cardiac toxicity. Electrocardiogram is indicated if cardiomyopathy ensues. A baseline electrocardiogram may also be useful prior to the start of carfilzomib.
*'''Use of [[carfilzomib]]'''<ref name="pmid25471129">{{cite journal| author=Chari A, Hajje D| title=Case series discussion of cardiac and vascular events following carfilzomib treatment: possible mechanism, screening, and monitoring. | journal=BMC Cancer | year= 2014 | volume= 14 | issue=  | pages= 915 | pmid=25471129 | doi=10.1186/1471-2407-14-915 | pmc=4289164 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25471129  }} </ref>: [[Carfilzomib]] is a second-generation [[proteasome inhibitor]] that is used in previously treated [[multiple myeloma]]. This medication is usually given along with either [[dexamethasone]] or the combination of [[lenalidomide]] plus [[dexamethasone]]. [[Carfilzomib]] is known to cause [[cardiomyopathy]] and [[cardiac]] [[toxicity]]. [[Electrocardiogram]] is indicated if [[cardiomyopathy]] ensues. A baseline [[electrocardiogram]] may also be useful prior to the start of [[carfilzomib]].
*'''Evaluation of cardiac amyloidosis'''<ref name="pmid22058156">{{cite journal| author=Guan J, Mishra S, Falk RH, Liao R| title=Current perspectives on cardiac amyloidosis. | journal=Am J Physiol Heart Circ Physiol | year= 2012 | volume= 302 | issue= 3 | pages= H544-52 | pmid=22058156 | doi=10.1152/ajpheart.00815.2011 | pmc=3353775 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22058156  }} </ref>: In some cases of multiple myeloma, there can be concurrent amyloidosis, which refers to systemic deposition of abnormally folded proteins called amyloid. Amyloid usually consists of ''lambda'' light chains, and amyloid can deposit in the cardiac tissue if there is excess free light chain production. Cardiac arrhythmias can occur if amyloid fibrils deposit in the electrical conduction system. This can result in low amplitude QRS complexes and heart block. Severe cardiac amyloidosis can cause significant infiltrative heart disease such that a high-degree atrioventricular block ensues. These changes can be detected readily on electrocardiogram. In some cases, serial electrocardiograms need to be done for routine cardiac monitoring.
*'''Evaluation of [[cardiac amyloidosis]]'''<ref name="pmid22058156">{{cite journal| author=Guan J, Mishra S, Falk RH, Liao R| title=Current perspectives on cardiac amyloidosis. | journal=Am J Physiol Heart Circ Physiol | year= 2012 | volume= 302 | issue= 3 | pages= H544-52 | pmid=22058156 | doi=10.1152/ajpheart.00815.2011 | pmc=3353775 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22058156  }} </ref>: In some cases of [[multiple myeloma]], there can be concurrent [[amyloidosis]], which refers to systemic deposition of abnormally folded [[proteins]] called [[amyloid]]. Amyloid usually consists of ''lambda'' [[Light chain|light chains,]] and [[amyloid]] can deposit in the [[cardiac]] [[tissue]] if there is excess free [[light chain]] production. [[Cardiac arrhythmias]] can occur if [[amyloid]] fibrils deposit in the electrical conduction system. This can result in low amplitude [[QRS complexes]] and [[heart block]]. Severe [[cardiac amyloidosis]] can cause significant infiltrative [[heart]] disease such that a high-degree [[atrioventricular block]] ensues. These changes can be detected readily on [[electrocardiogram]]. In some cases, serial [[electrocardiograms]] need to be done for routine [[Heart|cardiac]] monitoring.


==References==
==References==

Revision as of 14:47, 15 November 2018

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma electrocardiogram On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma electrocardiogram

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma electrocardiogram

CDC on Multiple myeloma electrocardiogram

Multiple myeloma electrocardiogram in the news

Blogs on Multiple myeloma electrocardiogram

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma electrocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

There are two indications for obtaining an electrocardiogram in the workup and management of multiple myeloma: carfilzomib use and evaluation of cardiac amyloidosis. In both of these situations, a baseline electrocardiogram may be useful. Subsequent electrocardiograms may be useful for monitoring. Electrocardiogram abnormalities include atrioventricular block and low voltage QRS complexes.

Electrocardiogram

There are two indications for obtaining an electrocardiogram in the workup and management of multiple myeloma:

References

  1. Chari A, Hajje D (2014). "Case series discussion of cardiac and vascular events following carfilzomib treatment: possible mechanism, screening, and monitoring". BMC Cancer. 14: 915. doi:10.1186/1471-2407-14-915. PMC 4289164. PMID 25471129.
  2. Guan J, Mishra S, Falk RH, Liao R (2012). "Current perspectives on cardiac amyloidosis". Am J Physiol Heart Circ Physiol. 302 (3): H544–52. doi:10.1152/ajpheart.00815.2011. PMC 3353775. PMID 22058156.


Template:WikiDoc Sources